Similar articles for PMID: 25175018

Year	Number of Results
1992	1
2001	1
2002	1
2003	2
2004	2
2005	2
2006	8
2007	7
2008	5
2009	8
2010	3
2011	8
2012	9
2013	6
2014	14
2015	21
2016	12
2017	9
2018	7
2019	3
2020	7
2021	6
2022	9
2023	1
2024	0

1

Proteomics biomarkers for non-small cell lung cancer.

Kisluk J, Ciborowski M, Niemira M, Kretowski A, Niklinski J. Kisluk J, et al. J Pharm Biomed Anal. 2014 Dec;101:40-9. doi: 10.1016/j.jpba.2014.07.038. Epub 2014 Aug 8. J Pharm Biomed Anal. 2014. PMID: 25175018 Review.

2

Application of proteomics in non-small-cell lung cancer.

Cho WC. Cho WC. Expert Rev Proteomics. 2016;13(1):1-4. doi: 10.1586/14789450.2016.1121813. Epub 2015 Dec 11. Expert Rev Proteomics. 2016. PMID: 26577456

3

Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.

Indovina P, Marcelli E, Pentimalli F, Tanganelli P, Tarro G, Giordano A. Indovina P, et al. Mass Spectrom Rev. 2013 Mar-Apr;32(2):129-42. doi: 10.1002/mas.21355. Epub 2012 Jul 24. Mass Spectrom Rev. 2013. PMID: 22829143 Review.

4

Proteome screening of pleural effusions identifies IL1A as a diagnostic biomarker for non-small cell lung cancer.

Li Y, Lian H, Jia Q, Wan Y. Li Y, et al. Biochem Biophys Res Commun. 2015 Feb 6;457(2):177-82. doi: 10.1016/j.bbrc.2014.12.083. Epub 2014 Dec 30. Biochem Biophys Res Commun. 2015. PMID: 25554695

5

[Research Progress of Biomakers Proteomics-based in Lung Cancer].

Xie H, Chen Z, Wang G. Xie H, et al. Zhongguo Fei Ai Za Zhi. 2015 Jun;18(6):391-6. doi: 10.3779/j.issn.1009-3419.2015.06.11. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26104898 Free PMC article. Review. Chinese.

6

Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome.

Wang CL, Wang CI, Liao PC, Chen CD, Liang Y, Chuang WY, Tsai YH, Chen HC, Chang YS, Yu JS, Wu CC, Yu CJ. Wang CL, et al. J Proteome Res. 2009 Oct;8(10):4428-40. doi: 10.1021/pr900160h. J Proteome Res. 2009. PMID: 19655816

7

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer.

Marrugal Á, Ojeda L, Paz-Ares L, Molina-Pinelo S, Ferrer I. Marrugal Á, et al. Dis Markers. 2016;2016:2138627. doi: 10.1155/2016/2138627. Epub 2016 Jun 30. Dis Markers. 2016. PMID: 27445423 Free PMC article. Review.

8

Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.

Sinchaikul S, Hongsachart P, Sriyam S, Tantipaiboonwong P, Phutrakul S, Chen ST. Sinchaikul S, et al. Chang Gung Med J. 2008 Sep-Oct;31(5):417-30. Chang Gung Med J. 2008. PMID: 19097588 Free article. Review.

9

Proteomic biomarkers of non-small cell lung cancer patients.

Baran K, Brzeziańska-Lasota E. Baran K, et al. Adv Respir Med. 2021;89(4):419-426. doi: 10.5603/ARM.a2021.0089. Adv Respir Med. 2021. PMID: 34494245 Free article. Review.

10

Personalized medicine and proteomics: lessons from non-small cell lung cancer.

Marko-Varga G, Ogiwara A, Nishimura T, Kawamura T, Fujii K, Kawakami T, Kyono Y, Tu HK, Anyoji H, Kanazawa M, Akimoto S, Hirano T, Tsuboi M, Nishio K, Hada S, Jiang H, Fukuoka M, Nakata K, Nishiwaki Y, Kunito H, Peers IS, Harbron CG, South MC, Higenbottam T, Nyberg F, Kudoh S, Kato H. Marko-Varga G, et al. J Proteome Res. 2007 Aug;6(8):2925-35. doi: 10.1021/pr070046s. Epub 2007 Jul 17. J Proteome Res. 2007. PMID: 17636986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

138 results

Results by year